Radiat Oncol J.
2013 Sep;31(3):162-170. 10.3857/roj.2013.31.3.162.
Role of adjuvant postoperative external beam radiotherapy for well differentiated thyroid cancer
- Affiliations
-
- 1Department of Radiation Oncology, Seoul National University College of Medicine, Seoul, Korea. wuhg@snu.ac.kr
- 2Cancer Research Institute, Seoul National University College of Medicine, Seoul, Korea.
- 3Institute of Radiation Medicine, Medical Research Center, Seoul National University, Seoul, Korea.
- 4Department of Surgery, Seoul National University College of Medicine, Seoul, Korea.
- 5Department of Otolaryngology, Seoul National University College of Medicine, Seoul, Korea.
- 6Department of Internal Medicine, Seoul National University College of Medicine, Seoul, Korea.
- KMID: 2051133
- DOI: http://doi.org/10.3857/roj.2013.31.3.162
Abstract
- PURPOSE
To analyze the outcome of adjuvant postoperative external beam radiotherapy (EBRT) in well-differentiated thyroid cancer (WDTC).
MATERIALS AND METHODS
We identified 84 patients treated with EBRT for WDTC from February 1981 to December 2010. Among them, we analyzed 39 patients who received EBRT after initial radical surgery. Twenty-four females and 15 males were included. The median age was 49 years (range, 16 to 72 years). There were 34 papillary thyroid carcinomas and 5 follicular thyroid carcinomas. Most patients showed pathologic T3/T4 stage (54%/26%). Ten patients (25.6%) had gross residual tumors. Five patients (12.8%) had tumor cells at the margin. The median EBRT dose and fraction size were 62.6 Gy and 1.8 to 2.0 Gy, respectively.
RESULTS
The median follow-up was 73 months (range, 21 to 372 months). The five-year overall survival (OS) and locoregional recurrence free survival (LRFS) were 97.4% and 86.9%, respectively. Locoregional failures occurred in 5 and all failure sites were the neck node area. In univariate analysis, OS was significantly influenced by invasion of the trachea (p = 0.016) or esophagus (p = 0.006). LRFS was significantly decreased by male (p = 0.020), gross residuum after resection (p = 0.002), close or positive tumor at surgical margin involvement (p = 0.044), and tracheal invasion (p = 0.040). No significant prognostic factor was identified in the multivariate analysis. No patient experienced the Radiation Therapy Oncology Group grade 3 or more toxicity.
CONCLUSION
Our locoregional control rate of 87.2% is comparable to historical controls with surgery alone, even though our study had a large proportion of advanced stage. Adjuvant EBRT may an effective and safe treatment option in patients with WDTC.
- Full Text Links
-
- Actions
-
Cited
- CITED
-
- Close
- Share
-
- Similar articles
-
- Korean Thyroid Association Guidelines on the Management of Differentiated Thyroid Cancers; Part I. Initial Management of Differentiated Thyroid Cancers - Chapter 7. Adjuvant External Beam Radiotherapy and Systemic Chemotherapy Following Thyroidectomy 2024
- Role of External Beam Radiotherapy in Patients with Locally Advanced Papillary Thyroid Cancer
- Postoperative Adjuvant Radiotherapy for Patients with Gastric Adenocarcinoma
- Differences in radiotherapy application according to regional disease characteristics of hepatocellular carcinoma
- Role of Radiotherapy in High-Risk Colon Cancer
